Learning Outcomes:
On completion of this module the students will have gained an extensive and thorough understanding of some of the key recombinant DNA technologies used in the biotechnology industry today. They will be able to critically evaluate the application of these technologies to human and animal disease. A critical part of the students training will be the ability to adapt these techniques to overcome problems that can arise during drug development.